ProCE Banner Activity

Applying New European Guideline Updates in AML: Experts Review Current Best Practice in Treatment and Molecular Testing

Slideset Download
Download these slides from a panel of international experts on the latest guideline updates for AML and how they impact clinical practice.

Released: October 24, 2022

Expiration: October 23, 2023

No longer available for credit.

Share

Faculty

Claudio Cerchione

Claudio Cerchione, MD, PhD

Romagnolo Institute for the Study of Tumors "Dino Amadori"
Hematology Unit
Medical Director/Researcher
Hematology Unit
Istituto Romagnolo per Lo Studio dei Tumori "Dino Amadori" - IRST IRCCS
Meldola, Italy

Adolfo de la Fuente Burguera

Adolfo de la Fuente Burguera, MD

Head of Hematology Department
MD Anderson CC Madrid
Madrid, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Servier Pharmaceuticals

Program Director Disclosure

Program Director

Claudio Cerchione, MD, PhD

Romagnolo Institute for the Study of Tumors "Dino Amadori"
Hematology Unit
Medical Director/Researcher
Hematology Unit
Istituto Romagnolo per Lo Studio dei Tumori "Dino Amadori" - IRST IRCCS
Meldola, Italy

Claudio Cerchione, MD, PhD: consultant/advisor/speaker: Glycomimetics, Menarini/Stemline

Adolfo de la Fuente Burguera, MD

Head of Hematology Department
MD Anderson CC Madrid
Madrid, Spain

Adolfo de la Fuente Burguera, MD: consultant/advisor/speaker: AbbVie, Astellas, Celgene/Bristol-Myers Squibb, Daiichi Sankyo, Incyte, Janssen-Cilag, Jazz Pharmaceuticals, Mundipharma, Novartis, Pfizer, Roche; researcher: BTG, Janssen-Cilag, Novartis